Spironolactone and hydroflumethiazide in the treatment of hypertension
Akbar, F.A.; Boston, P.F.; Chapman, J.; Pearce, M.Y.
British Journal of Clinical Practice 35(9): 317-321
1981
ISSN/ISBN: 0007-0947 PMID: 7034762 Document Number: 181638
Document emailed within 1 workday
Related Documents
Jamil, M.A. 1971: A comparative study of spironolactone and hydroflumethiazide alone and together in the treatment of hypertension Guy's Hospital Reports 120(3): 207-219Widimský, Jří. 2015: PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension Vnitrni Lekarstvi 61(12): 1067-1071
Fagerberg, S.E.; Göransson, K. 1974: A comparative study of spironolactone and chlorthalidone in treatment of hypertension Lakartidningen 71(3): 175-177
Rhomberg, F. 1977: Detection of the optimal dose of spironolactone for the treatment of benign essential hypertension Schweizerische Medizinische Wochenschrift 107(35): 1228-1232
Mauro, B.; Savagnone, E. 1979: The combination of propranolol, hydrochlorothiazide and spironolactone in the treatment of essential arterial hypertension Bollettino Della Societa Italiana di Cardiologia 24(2): 189-196
Kreeft, J.H.; Larochelle, P.; Ogilvie, R.I. 1983: Comparison of chlorthalidone and spironolactone in low--renin essential hypertension Canadian Medical Association Journal 128(1): 31-34
Di Veroli, C.; Compagno, S.; Iugoli, A.R. 1982: Spironolactone and propranolol in combination therapy of arterial hypertension La Clinica Terapeutica 103(3): 283-287
Orabona, M.L.; Maiorano, G.; Loiacono, N. 1975: Spironolactone in essential hypertension. Controlled study on the dose-response relationship Minerva Cardioangiologica 23(12): 866-870
Pinto, J.M. 1981: Evaluation of a spironolactone and althiazide combination (aldactacine) in Africans with benign essential hypertension East African Medical Journal 58(1): 44-50
Tosti-Croce, C.; Mantellini, R.; Fanti, P.; Sciarra, F. 1983: Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension Minerva Medica 74(14-15): 791-797
Woodhouse, N.J.; Elshafie, O.T.; Mehar, A.; Johnston, W.J.; Al-Kaabi, J.M. 2003: Spironolactone responsive familial hypertension. a potentially high prevalence of mineralocorticoid disease in Oman Saudi Medical Journal 24(2): 229-231
Kjaerulff, J.; Lyngsoe, J. 1973: The antihypertensive effects of bendroflumethiazide, hydroflumethiazide, trichlormethiazide, chlorthalidone and furosemide Ugeskrift for Laeger 135(33): 1744-1746
Blum, I.; Kaufman, H.; Marilus, R.; Rusecki, Y.; Chovers, I. 1981: Successful treatment of polycystic ovary syndrome with spironolactone or bromocriptine Obstetrics and Gynecology 57(5): 661-665
Komarov, E.K.; Svechnikova, F.A.; Khrustaleva, G.F. 1985: State of the hypothalamo-hypophyseo-ovarian function in patients with hyperandrogenemia during treatment with spironolactone Akusherstvo i Ginekologiia 9: 60-61
Daum, S.; Goerg, R.; Mack, D.; Wang, D. 1984: Heart failure therapy with digitalis and spironolactone--studies within the scope of preoperative treatment before lung resection Praxis und Klinik der Pneumologie 38(9): 406-411
Erbler, H.C. 1979: Effect of spironolactone and its main metabolite canrenone on the renin-angiotensin-aldosterone-system during long-term treatment in rats Acta Endocrinologica 90(1): 147-156
Johannesson, M.; Borgqvist, L.; Jönsson, B.; Råstam, L. 1991: Treatment of hypertension in Sweden: treatment of patients with hypertension costs more than a billion crowns per year Lakartidningen 88(12): 1103-1106
Bendtzen, K.; Hansen, P.R.; Rieneck, K. 2004: Spironolactone inhibits production of proinflammatory cytokines, including tumor necrosis factor-alpha and interferon-gamma and has potential effect in the treatment of arthritis Ugeskrift for Laeger 166(37): 3203-3207
Hayduk, K. 1989: Treatment of hypertension 1989. Recommendations of the German League for the Control of Hypertension Fortschritte der Medizin 107(24): 507-509
Moiseev, V.S.; Konurina, I.I.; Krasnobaeva, G.M.; Ivleva, A.I. 1995: Significance of assessment of natriuresis and diuresis in the course of isradipine treatment of hypertension in patients with hypertension and type Ii diabetes Klinicheskaia Laboratornaia Diagnostika 1: 18-20